Welcome to our dedicated page for Valens Semiconductor SEC filings (Ticker: VLN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Tracking how HDBaseT royalties translate into revenue growth or when Valens Semiconductor’s R&D spend will pay off shouldn’t require combing through hundreds of dense pages. Yet the company’s 10-K, 10-Q, and frequent 8-K updates are packed with technical jargon about chip fabrication, automotive design-win pipelines, and multi-segment accounting.
Stock Titan solves that problem. Our AI-powered summaries translate complex disclosures into clear insights—highlighting where MIPI A-PHY adoption shows up in revenue, flagging risk-factor changes, and surfacing real-time Form 4 alerts the moment insiders trade. Whether you need Valens Semiconductor insider trading Form 4 transactions or a quick read-through of the latest quarterly earnings report 10-Q filing, you’ll find every document the instant it hits EDGAR.
Use cases our clients rely on:
- Valens Semiconductor Form 4 insider transactions real-time
- Valens Semiconductor SEC filings explained simply
- Valens Semiconductor earnings report filing analysis
- understanding Valens Semiconductor SEC documents with AI
- Valens Semiconductor executive stock transactions Form 4
- Valens Semiconductor annual report 10-K simplified
- Valens Semiconductor proxy statement executive compensation
- Valens Semiconductor 8-K material events explained
Every filing—from the briefest 8-K to the sprawling annual report—arrives with expert commentary, keyword search, and downloadable tables. Monitor segment performance across Cross-Industry and Automotive units, compare HDBaseT versus USB3 extension revenue, or track director stock grants without leaving this page. Save hours, gain clarity, and make informed decisions faster.
Valens Semiconductor Ltd. (VLN) Form 144 discloses a proposed sale of 1,422,700 common shares through Oppenheimer & Co., with an aggregate market value of $2,882,247.93. The filing lists an approximate date of sale of 08/08/2025 and the securities exchange as NYSE. The shares were acquired in a private placement on 01/01/2020.
The notice also reports securities sold during the past three months: Linse Capital LLC sold 1,523,723 common shares on 05/23/2025 for gross proceeds of $3,443,387.00. The filing includes broker details and the filer’s representation that no undisclosed material adverse information is known.
Valens Semiconductor Ltd. (VLN) has filed a Form 144 indicating that Cynara Ltd., acting for Tal Yaacobi, intends to sell 2,050 ordinary shares through Oppenheimer & Co. on or about 15 July 2025. The sale is valued at $5,576, implying a price near $2.72 per share. The shares were obtained on 15 Jan 2025 via Restricted Stock Units. Over the last three months the same seller disposed of 3,450 shares for proceeds of $8,328. With 106.3 million shares outstanding, the planned sale equals roughly 0.002 % of the float, indicating negligible dilution or market impact. The filer attests to having no undisclosed material information, suggesting this is routine liquidity rather than a signal of fundamental concern.
The Form 144 filing discloses that Valens Semiconductor Ltd. (VLN) Chairman David, an officer of the company, plans to sell 1,194 ordinary shares through broker Oppenheimer & Co. on 26 June 2025 under an existing Rule 10b5-1 trading plan adopted 16 Aug 2024. The proposed sale has an estimated market value of US $2,865.60, based on recent trading prices.
This notice also details the insider’s prior activity: within the last three months he sold 8,000 shares on 14 Apr 2025 and 6,806 shares on 25 Jun 2025, generating combined gross proceeds of US $37,109.92. All shares originated from employee stock-option grants received on 11 Jan 2019. After the proposed transaction, the total shares to be sold represent less than 0.002% of the company’s 106.3 million shares outstanding, indicating a de minimis impact on the public float. No adverse, non-public information is asserted by the filer, as required by Form 144 certification.